Mettler-Toledo International Inc. (NYSE: MTD) has released its financial results for the second quarter of 2024. Key highlights include: Second Quarter Highlights Management Commentary Patrick Kaltenbach, President and CEO, commented,…
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company specializing in innovative treatments for neurological diseases, has announced the grant of inducement awards to two new employees. The Compensation Committee…
Owens & Minor, Inc. (NYSE: OMI) Announces Second Quarter Financial Results for 2024 Owens & Minor, Inc. (NYSE: OMI) has released its financial results for the second quarter ending June…
Twist Bioscience Corporation (NASDAQ: TWST), known for its high-quality synthetic DNA via its silicon platform, has reported its financial results and business highlights for the third quarter of fiscal 2024,…
Hologic, Inc. (Nasdaq: HOLX) has announced its financial results for the fiscal third quarter ending June 29, 2024. “We delivered another strong financial performance in Q3 2024, marked by sequential…
Good Neighbor Pharmacy, a national network under Cencora, celebrated independent pharmacy excellence at its annual conference, ThoughtSpot 2024, held from July 24-27 at the Marriott World Center in Orlando, Fla.…
Centene Corporation (NYSE: CNC) has announced its financial results for the second quarter ending June 30, 2024. Here’s a summary of the key figures: Note: Adjusted EPS and SG&A Expense…
Bristol Myers Squibb (NYSE: BMY) has announced its financial results for Q2 2024. Highlights: Second Quarter Financials: Product Revenue Highlights: Product and Pipeline Updates: Financial Guidance for 2024: Bristol Myers…
Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, has announced a new study in the Journal of Clinical Oncology showcasing the effectiveness of its personalized molecular residual disease…
Amprion, a leader in advancing the diagnosis of neurodegenerative disorders through seed amplification testing, is unveiling its new line of cerebrospinal fluid (CSF) biomarker panels under the SAAmplify brand. These…
Maverick Medical AI has announced a significant expansion of its presence in the United States through a new partnership with a leading national medical provider specializing in the outpatient radiology…
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing cancer treatments, has announced the pricing of its underwritten public offering. The offering consists of 13,333,334 shares of common stock…